Hospital-Acquired Disease Testing Market to Reach USD 724 Million by 2031 | CAGR 5.6%
According to a newly published market research report by 24LifeSciences, global hospital-acquired disease testing market was valued at USD 498 million in 2024 and is projected to reach USD 724 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period 2026–2034. Hospital-acquired infections (HAIs), clinically significant as nosocomial...
0 Commentarii 0 Distribuiri 257 Views 0 previzualizare